Technical Analysis for NUVO - Holdco Nuvo Group D.G Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.54 | -5.52% | -0.09 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -5.52% | |
| Narrow Range Bar | Range Contraction | -5.52% | |
| New 52 Week Low | Weakness | -5.52% | |
| Wide Bands | Range Expansion | -5.52% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 4 days ago |
| Down 5% | 4 days ago |
| Down 3% | 4 days ago |
| Fell Below Previous Day's Low | 4 days ago |
| Down 2 % | 4 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: Unknown
Holdco Nuvo Group D.G Ltd. Description
Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo's INVU™ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that Nuvo believes can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo plans to continue to expand the footprint of sales in the US and Israel and plans to introduce its INVU platform in Europe in 2024, subject to granting of the CE mark it filed in Europe in March 2023, to provide remote access and insights not previously deemed possible. Nuvo is led by a diverse team of experienced business, medical and technology leaders, united in the mission of breaking down barriers to pregnancy care to give every life a better beginning.
Classification
Sector: Financial Services
Industry: Shell Companies
Keywords: FDA Obstetrics Childbirth Women's Health Midwifery Pregnancy Prenatal Testing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.5 |
| 52 Week Low | 1.51 |
| Average Volume | 1,051,680 |
| 200-Day Moving Average | 9.71 |
| 50-Day Moving Average | 6.68 |
| 20-Day Moving Average | 3.17 |
| 10-Day Moving Average | 1.84 |
| Average True Range | 0.97 |
| RSI (14) | 32.43 |
| ADX | 17.08 |
| +DI | 17.56 |
| -DI | 23.89 |
| Chandelier Exit (Long, 3 ATRs) | 5.64 |
| Chandelier Exit (Short, 3 ATRs) | 4.43 |
| Upper Bollinger Bands | 7.22 |
| Lower Bollinger Band | -0.88 |
| Percent B (%b) | 0.3 |
| BandWidth | 255.39 |
| MACD Line | -1.52 |
| MACD Signal Line | -1.60 |
| MACD Histogram | 0.0755 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.86 | ||||
| Resistance 3 (R3) | 1.88 | 1.80 | 1.80 | ||
| Resistance 2 (R2) | 1.80 | 1.72 | 1.79 | 1.78 | |
| Resistance 1 (R1) | 1.67 | 1.67 | 1.63 | 1.65 | 1.77 |
| Pivot Point | 1.59 | 1.59 | 1.57 | 1.58 | 1.59 |
| Support 1 (S1) | 1.46 | 1.51 | 1.42 | 1.44 | 1.31 |
| Support 2 (S2) | 1.38 | 1.46 | 1.37 | 1.30 | |
| Support 3 (S3) | 1.25 | 1.38 | 1.28 | ||
| Support 4 (S4) | 1.23 |
